|
|||||
|
|
EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma |
|
| Authors: | Irene Papadouli Jan Mueller-Berghaus Claire Beuneu Sahra Ali Benjamin Hofner Frank Petavy Kyriaki Tzogani Anne Miermont Koenraad Norga Olga Kholmanskikh Tim Leest Martina Schuessler-Lenz Tomas Salmonson Christian Gisselbrecht Jordi Llinares Garcia Francesco Pignatti |
| Affiliation: | 1. European Medicines Agency, Amsterdam, The Netherlands;2. Paul-Ehrlich-Institut, Langen, Germany;3. Federal Agency for Medicines and Health Products, Brussels, Belgium;4. Federal Agency for Medicines and Health Products, Brussels, Belgium Paediatric Oncology, Antwerp University Hospital, Edegem, Belgium;5. Medical Products Agency, Uppsala, Sweden;6. Hôpital Saint Louis Institut d'Hématologie, Paris, France |
| Abstract: | |
| Keywords: | Diffuse large B-cell lymphoma Primary mediastinal B-cell lymphoma Chimeric antigen receptor Axicabtagene ciloleucel Cytokine release syndrome CAT CHMP |